Market Cap (In AUD)
8.32 Million
Revenue (In AUD)
1.2 Million
Net Income (In AUD)
-1.44 Million
Avg. Volume
11.82 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.02-0.05
- PE
- -
- EPS
- -
- Beta Value
- -0.616
- ISIN
- AU0000179475
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Darryl Davies B.Sc.
- Employee Count
- -
- Website
- https://inhalerx.com.au
- Ipo Date
- 2017-01-10
- Details
- InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Sydney, Australia.
More Stocks
-
QLIS
-
688569
-
AMNP
-
IMPJYWebuild S.p.A.
IMPJY
-
605166
-
ABDA
-
688051
-
ASTR